Filed: 8/11/2026ACC: 0001193125-26-345031
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 76 equity positions with a total reported market value of $664.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
76
Positions
$664.51M
Total AUM (reported)
60.98M
Total Shares
Allocation by class
COM$342.68M51.6%
CLASS A COM STK$239.00M36.0%
COM SHS$29.02M4.4%
CL C$14.22M2.1%
COM NEW$12.30M1.9%
COM SER A$9.74M1.5%
CALL$6.51M1.0%
Portfolio Concentration
Top 3$365.99M55.1%
4–10$155.93M23.5%
11–25$109.39M16.5%
Rest$33.20M5.0%
Top 3 weight
55.1%
Top 10 weight
78.5%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other76
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings76
Rows:
SPACE EXPLORATION TECHN CORP
DFNDShares1.40M
TypeSH
Market value$239.00M
35.97%
Sole
0.00
Shared
0.00
None
0.00
AKTIS ONCOLOGY INC
DFNDShares3.07M
TypeSH
Market value$98.95M
14.89%
Sole
0.00
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares1.54M
TypeSH
Market value$28.04M
4.22%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares9.16M
TypeSH
Market value$27.95M
4.21%
Sole
0.00
Shared
0.00
None
0.00
NUVEEN CHURCHILL DIRECT LEND
DFNDShares2.14M
TypeSH
Market value$26.62M
4.01%
Sole
0.00
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
DFNDShares729.93K
TypeSH
Market value$26.16M
3.94%
Sole
0.00
Shared
0.00
None
0.00
CAPITAL ONE FINL CORP
DFNDShares119.76K
TypeSH
Market value$24.03M
3.62%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$22.23M
3.35%
Sole
0.00
Shared
0.00
None
0.00
DEEP FISSION INC
DFNDShares1.33M
TypeSH
Market value$14.72M
2.22%
Sole
0.00
Shared
0.00
None
0.00
DELL TECHNOLOGIES INC
DFNDShares32.96K
TypeSH
Market value$14.22M
2.14%
Sole
0.00
Shared
0.00
None
0.00
HOLLEY INC
DFNDShares4.38M
TypeSH
Market value$11.16M
1.68%
Sole
0.00
Shared
0.00
None
0.00
EYEPOINT INC
DFNDShares762.59K
TypeSH
Market value$10.91M
1.64%
Sole
0.00
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares1.26M
TypeSH
Market value$9.74M
1.47%
Sole
0.00
Shared
0.00
None
0.00
CORVUS PHARMACEUTICALS INC
DFNDShares608.60K
TypeSH
Market value$9.09M
1.37%
Sole
0.00
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
DFNDShares874.54K
TypeSH
Market value$8.48M
1.28%
Sole
0.00
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares3.62M
TypeSH
Market value$7.94M
1.19%
Sole
0.00
Shared
0.00
None
0.00
CONDUENT INC
DFNDShares5.04M
TypeSH
Market value$7.35M
1.11%
Sole
0.00
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
DFNDShares61.45K
TypeSH
Market value$6.82M
1.03%
Sole
0.00
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
DFNDShares450K
TypeSH
Market value$6.37M
0.96%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares182.64K
TypeSH
Market value$6.10M
0.92%
Sole
0.00
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC NE
DFNDShares36.26K
TypeSH
Market value$5.54M
0.83%
Sole
0.00
Shared
0.00
None
0.00
IMAGENEBIO INC
DFNDShares917.69K
TypeSH
Market value$5.41M
0.81%
Sole
0.00
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
DFNDShares1.67M
TypeSH
Market value$5.18M
0.78%
Sole
0.00
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
DFNDShares260K
TypeSH
Market value$4.78M
0.72%
Sole
0.00
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
DFNDShares437.55K
TypeSH
Market value$4.51M
0.68%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPACE EXPLORATION TECHN CORPDFND | CLASS A COM STK | 1.40M | SH | $239.00M 35.97% | 0.00 | 0.00 | 0.00 |
AKTIS ONCOLOGY INCDFND | COM | 3.07M | SH | $98.95M 14.89% | 0.00 | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 1.54M | SH | $28.04M 4.22% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 9.16M | SH | $27.95M 4.21% | 0.00 | 0.00 | 0.00 |
NUVEEN CHURCHILL DIRECT LENDDFND | COM SHS | 2.14M | SH | $26.62M 4.01% | 0.00 | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 729.93K | SH | $26.16M 3.94% | 0.00 | 0.00 | 0.00 |
CAPITAL ONE FINL CORPDFND | COM | 119.76K | SH | $24.03M 3.62% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $22.23M 3.35% | 0.00 | 0.00 | 0.00 |
DEEP FISSION INCDFND | COM | 1.33M | SH | $14.72M 2.22% | 0.00 | 0.00 | 0.00 |
DELL TECHNOLOGIES INCDFND | CL C | 32.96K | SH | $14.22M 2.14% | 0.00 | 0.00 | 0.00 |
HOLLEY INCDFND | COM | 4.38M | SH | $11.16M 1.68% | 0.00 | 0.00 | 0.00 |
EYEPOINT INCDFND | COM NEW | 762.59K | SH | $10.91M 1.64% | 0.00 | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 1.26M | SH | $9.74M 1.47% | 0.00 | 0.00 | 0.00 |
CORVUS PHARMACEUTICALS INCDFND | COM | 608.60K | SH | $9.09M 1.37% | 0.00 | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCDFND | COM | 874.54K | SH | $8.48M 1.28% | 0.00 | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 3.62M | SH | $7.94M 1.19% | 0.00 | 0.00 | 0.00 |
CONDUENT INCDFND | COM | 5.04M | SH | $7.35M 1.11% | 0.00 | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCDFND | COM | 61.45K | SH | $6.82M 1.03% | 0.00 | 0.00 | 0.00 |
COMPASS PATHWAYS PLCDFND | SPONSORED ADS | 450K | SH | $6.37M 0.96% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 182.64K | SH | $6.10M 0.92% | 0.00 | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INC NEDFND | COM | 36.26K | SH | $5.54M 0.83% | 0.00 | 0.00 | 0.00 |
IMAGENEBIO INCDFND | COM | 917.69K | SH | $5.41M 0.81% | 0.00 | 0.00 | 0.00 |
COMPASS PATHWAYS PLCDFND | CALL | 1.67M | SH | $5.18M 0.78% | 0.00 | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCDFND | COM | 260K | SH | $4.78M 0.72% | 0.00 | 0.00 | 0.00 |
IMMIX BIOPHARMA INCDFND | COM | 437.55K | SH | $4.51M 0.68% | 0.00 | 0.00 | 0.00 |
Page 1 of 4